Mardi C. Dier

2015

In 2015, Mardi C. Dier earned a total compensation of $2.7M as Executive Vice President and Chief Financial Officer at Portola Pharmaceuticals, a 49% increase compared to previous year.

Compensation breakdown

Bonus$19,997
Non-Equity Incentive Plan$159,975
Option Awards$1,000,210
Salary$390,710
Stock Awards$1,126,115
Other$16,746
Total$2,713,753

Dier received $1.1M in stock awards, accounting for 41% of the total pay in 2015.

Dier also received $20K in bonus, $160K in non-equity incentive plan, $1M in option awards, $390.7K in salary and $16.7K in other compensation.

Rankings

In 2015, Mardi C. Dier's compensation ranked 3,539th out of 13,638 executives tracked by ExecPay. In other words, Dier earned more than 74.1% of executives.

ClassificationRankingPercentile
All
3,539
out of 13,638
74th
Division
Manufacturing
1,288
out of 5,190
75th
Major group
Chemicals And Allied Products
468
out of 1,854
75th
Industry group
Drugs
374
out of 1,528
76th
Industry
Pharmaceutical Preparations
294
out of 1,182
75th
Source: SEC filing on April 24, 2017.

Dier's colleagues

We found three more compensation records of executives who worked with Mardi C. Dier at Portola Pharmaceuticals in 2015.

2015

William Lis

Portola Pharmaceuticals

Chief Executive Officer

2015

Tao Fu

Portola Pharmaceuticals

Executive Vice President, Chief Commercial and Business Officer

2015

John Curnutte

Portola Pharmaceuticals

Executive Vice President, Research and Development

News

You may also like